Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E Hegi, Warren P Mason, Martin J van den Bent, Martin JB Taphoorn, Robert C Janzer, Samuel K Ludwin, Anouk Allgeier, Barbara Fisher, Karl Belanger, Peter Hau, Alba A Brandes, Johanna Gijtenbeek, Christine Marosi, Charles J Vecht, Karima Mokhtari, Pieter Wesseling, Salvador Villa, Elizabeth Eisenhauer, Thierry Gorlia, Michael Weller, Denis Lacombe, J Gregory Cairncross, René-Olivier Mirimanoff

Open source

DOI: 10.1016/s1470-2045(09)70025-7
Published: 2009-05
Container: The Lancet Oncology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-09-70025-7,
  title = {Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial},
  author = {Roger Stupp and Monika E Hegi and Warren P Mason and Martin J van den Bent and Martin JB Taphoorn and Robert C Janzer and Samuel K Ludwin and Anouk Allgeier and Barbara Fisher and Karl Belanger and Peter Hau and Alba A Brandes and Johanna Gijtenbeek and Christine Marosi and Charles J Vecht and Karima Mokhtari and Pieter Wesseling and Salvador Villa and Elizabeth Eisenhauer and Thierry Gorlia and Michael Weller and Denis Lacombe and J Gregory Cairncross and René-Olivier Mirimanoff},
  year = {2009},
  journal = {The Lancet Oncology},
  doi = {10.1016/s1470-2045(09)70025-7},
  url = {https://doi.org/10.1016/s1470-2045(09)70025-7}
}

RIS

TY  - JOUR
TI  - Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
AU  - Roger Stupp
AU  - Monika E Hegi
AU  - Warren P Mason
AU  - Martin J van den Bent
AU  - Martin JB Taphoorn
AU  - Robert C Janzer
AU  - Samuel K Ludwin
AU  - Anouk Allgeier
AU  - Barbara Fisher
AU  - Karl Belanger
AU  - Peter Hau
AU  - Alba A Brandes
AU  - Johanna Gijtenbeek
AU  - Christine Marosi
AU  - Charles J Vecht
AU  - Karima Mokhtari
AU  - Pieter Wesseling
AU  - Salvador Villa
AU  - Elizabeth Eisenhauer
AU  - Thierry Gorlia
AU  - Michael Weller
AU  - Denis Lacombe
AU  - J Gregory Cairncross
AU  - René-Olivier Mirimanoff
PY  - 2009
JO  - The Lancet Oncology
DO  - 10.1016/s1470-2045(09)70025-7
UR  - https://doi.org/10.1016/s1470-2045(09)70025-7
ER  -

APA

Stupp, R., Hegi, M. E., Mason, W. P., Bent, M. J. V. D., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., Hau, P., Brandes, A. A., Gijtenbeek, J., Marosi, C., Vecht, C. J., Mokhtari, K., Wesseling, P., Villa, S., Eisenhauer, E., Gorlia, T., Weller, M., Lacombe, D., Cairncross, J. G., & Mirimanoff, R. (2009). Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(09)70025-7

Source records

crossref · retrieved 2026-11-07T23:27:57.089Z